Staging in bipolar disorder: from theoretical framework to clinical utility

Area of Science:

• Psychiatry
• Neuroscience
• Clinical Psychology

Background:

• Illness staging is crucial for predicting prognosis and optimizing treatment across medical disciplines.
• Psychiatric staging models, particularly for bipolar disorder, posit a predictable progression from at-risk stages to recurrent episodes and potential late-stage manifestations.
• The validity of staging hinges on its correlation with clinical outcomes, treatment responses, and neurobiological markers.

Purpose of the Study:

• To evaluate the evidence supporting descriptive staging of bipolar disorder.
• To review preliminary validation attempts of bipolar disorder staging models.
• To recommend future research directions and outline clinical implications of staging for bipolar disorder.

Main Methods:

• Review of existing literature on illness staging in psychiatry and bipolar disorder.
• Analysis of evidence linking staging to clinical outcomes, treatment response, and neurobiological changes.
• Exploration of potential stage-specific treatment strategies.

Main Results:

• Staging models imply an active disease process that can lead to neuroprogression and functional decline if untreated.
• Biological factors like genetic predisposition, trauma, inflammation, and oxidative stress are implicated in bipolar disorder progression.
• Stage-specific treatments, from prevention to palliative care, are proposed to target symptom reduction and impede neuroprogression.

Conclusions:

• Further research is needed to validate bipolar disorder staging models.
• Stage-specific interventions hold promise for improving long-term outcomes and potentially modifying illness course.
• Bipolar disorder staging may offer a transdiagnostic framework for understanding and managing the illness.